Hip Fracture

DBCOND0029564Musculoskeletal and Connective Tissue DiseasesWounds and Injuries

Hip Fracture is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Hip Fractures · Fractured Hip · Trochanteric Fractures · Hip-fracture · Fracture of Hip
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0010366ICD-10S72.0SNOMED CT157233005MedDRA10006387UMLSC0015806

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
196Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hip Fracture share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In